Document is current

Any future updates will be listed below

A phase II study of biweekly S-1 and paclitaxel (SPA) as first-line chemotherapy in patients with metastatic or advanced gastric cancer

Crossref DOI link: https://doi.org/10.1007/s00280-015-2782-z

Published Online: 2015-05-27

Published Print: 2015-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark